| 000 | 01572 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517234543.0 | ||
| 264 | 0 | _c20200116 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1096-9071 | ||
| 024 | 7 |
_a10.1002/jmv.25298 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSong, Shaohui | |
| 245 | 0 | 0 |
_aAn adjuvant compound that enhances immunogenicity at fractional doses of the Sabin-inactivated poliovirus vaccine (sIPV) with a long duration of protection in a rat model. _h[electronic resource] |
| 260 |
_bJournal of medical virology _c01 2019 |
||
| 300 |
_a14-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcrylates _xadministration & dosage |
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Viral _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPoliovirus Vaccine, Inactivated _xadministration & dosage |
| 650 | 0 | 4 |
_aPolysorbates _xadministration & dosage |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSeroconversion |
| 650 | 0 | 4 |
_aSqualene _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLiu, Ze | |
| 700 | 1 | _aZhou, Jian | |
| 700 | 1 | _aCai, Wei | |
| 700 | 1 | _aYang, Huijuan | |
| 700 | 1 | _aMa, Lei | |
| 700 | 1 | _aGao, Jingxia | |
| 700 | 1 | _aLi, Weidong | |
| 700 | 1 | _aLiao, Guoyang | |
| 773 | 0 |
_tJournal of medical virology _gvol. 91 _gno. 1 _gp. 14-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.25298 _zAvailable from publisher's website |
| 999 |
_c28789660 _d28789660 |
||